The DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Association between Blood Pressure and Serum Thyroid-Stimulating Hormone Concentration within the Reference Range: A Population-Based Study
Abstract
CONTEXT: The association between thyroid function and blood pressure is insufficiently studied. OBJECTIVE: The objective of the investigation was to study the association between TSH within the reference range and blood pressure. DESIGN AND SETTING: This was a cross-sectional, population-based study. SUBJECTS: A total of 30,728 individuals without previously known thyroid disease were studied. MAIN OUTCOME MEASURES: The main outcome measures were mean systolic and diastolic blood pressure and pulse pressure and odds ratio for hypertension (>140/90 mm Hg or current or previous use of antihypertensive medication), according to categories of TSH. RESULTS: Within the reference range of TSH (0.50-3.5 mU/liter), there was a linear increase in blood pressure with increasing TSH. The average increase in systolic blood pressure was 2.0 mm Hg [95% confidence interval (CI) 1.4-2.6 mm Hg] per milliunit per liter increase in TSH among men, and 1.8 mm Hg (95% CI 1.4-2.3 mm Hg) in women. The corresponding increase in diastolic blood pressure was 1.6 mm Hg (95% CI 1.2-2.0 mm Hg) in men and 1.1 mm Hg (95% CI 0.8-1.3 mm Hg) in women. Comparing TSH of 3.0-3.5 mU/liter (upper part of the reference) with TSH of 0.50-0.99 mU/liter (lower part of the reference), the odds ratio for hypertension was 1.98 (95% CI 1.56-2.53) in men and 1.23 (95% CI 1.04-1.46) in women. CONCLUSION: Within the reference range of TSH, we found a linear positive association between TSH and systolic and diastolic blood pressure that may have long-term implications for cardiovascular health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within the reference range of 0.50–3.5 mU/L, blood pressure increased linearly with increasing TSH (SBP by 2.0 mmHg in men and 1.8 mmHg in women, DBP increased by 1.6 and 1.1 mmHg) (101).”
From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [101]
In the citing paper
“For instance, comparing TSH of 3.0–3.5 mU/L with 0.50–0.99 mU/L, the OR for hypertension was 1.98 in men and 1.23 in women (101).”
From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [101]
In the citing paper
“In particular higher levels of TSH were associated with worsening of both blood pressure [58–60] and lipid levels [61, 62] although these effects were modest.”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [59]
Citations
Cites
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Hypothyroidism and Atherosclerosis
Cappola, A. R., & Ladenson, P. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030398 · Cited by 640
The Nord-Trøndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation
Holmen, J., Midthjell, K., Krüger, Ø., Langhammer, A., Holmen, T. L., Bratberg, G. H., Vatten, L., & Lund‐Larsen, P. G. (2003) · Cited by 526
Bjøro, T., Holmen, J., Krüger, Ø., Midthjell, K., Hunstad, K., Schreiner, T., Sandnes, L., & Brochmann, H. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430639 · Cited by 463
Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D., Ghiadoni, L., Salvetti, A., Ferrannini, E., & Monzani, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030039 · Cited by 431
Åsvold, B. O., Vatten, L. J., Nilsen, T. I. L., & Bjøro, T. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02333 · Cited by 350
Self-citationThe Thyrotropin Reference Range Should Remain Unchanged
Surks, M. I., Goswami, G., & Daniels, G. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0170 · Cited by 287
Risk Factors for Cardiovascular Disease in Women with Subclinical Hypothyroidism
Luboshitzky, R., Aviv, A., Herer, P., & Lavie, L. (2002) · Thyroid · doi:10.1089/105072502760043512 · Cited by 238
Lekakis, J. P., Papamichael, C. M., Alevizaki, M. K., Gd, P., MARAFELIA, P., Mantzos, J. D., Stamatelopoulos, S., & Koutras, D. A. (1997) · Thyroid · doi:10.1089/thy.1997.7.411 · Cited by 236
Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension.
Streeten, D. H., Anderson, G. H., Howland, T., Chiang, R., & Smulyan, H. (1988) · Hypertension · doi:10.1161/01.hyp.11.1.78 · Cited by 172
Hyperthyroidism: A Secondary Cause of Isolated Systolic Hypertension
Prisant, L. M., Gujral, J., & Mulloy, A. L. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05180.x · Cited by 152
Increased central arterial stiffness in hypothyroidism
Obuobie, K., Smith, J., Evans, L. M., John, R., Davies, J. S., & Lazarus, J. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020493 · Cited by 119
Subclinical thyroid dysfunction and blood pressure: a community‐based study
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02619.x · Cited by 117
Dernellis, J., & Panaretou, M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120766 · Cited by 115
Subclinical Hypothyroidism, Arterial Stiffness, and Myocardial Reserve
Owen, P., Rajiv, C., Vinereanu, D., Mathew, T., Fraser, A. G., & Lazarus, J. H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2108 · Cited by 110
Thyroid Function and Blood Pressure Homeostasis in Euthyroid Subjects
Gumieniak, O., Perlstein, T. S., Hopkins, P. N., Brown, N. J., Murphey, L. J., Jeunemaı̂tre, X., Hollenberg, N. K., & Williams, G. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032143 · Cited by 105
Hypertension in Thyroid Disorders
Saito, I., & Samta, T. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30103-8 · Cited by 93
Arterial stiffness is increased in subjects with hypothyroidism
Dagre, A. G., Lekakis, J. P., Papaioannou, T. G., Papamichael, C. M., Koutras, D. A., Stamatelopoulos, S., & Alevizaki, M. K. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.05.068 · Cited by 87
Hemodynamic Changes After Levothyroxine Treatment in Subclinical Hypothyroidism
Faber, J. O., Petersen, L. R., Wiinberg, N., Schifter, S., & Mehlsen, J. (2002) · Thyroid · doi:10.1089/10507250252949450 · Cited by 81
Hypertension and hypothyroidism
Fletcher, A., & Weetman, A. (1998) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000574 · Cited by 77
Blood pressure in relation to serum thyrotropin: the Tromsø study
Iqbal, A., Figenschau, Y., & Jorde, R. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002091 · Cited by 72
The association between subclinical hyperthyroidism and blood pressure in a population-based study
Völzke, H., Alte, D., Dörr, M., Wallaschofski, H., John, U., Felix, S. B., & Rettig, R. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000244942.57417.8e · Cited by 54
Pulse Pressure as a Risk Factor
Franklin, S. S. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200031962 · Cited by 52
REVERSIBLE HYPERTENSION AND HYPOTHYROIDISM
Bing, R. F., BRIGGS, R. S. J., Burden, A. C., RUSSELL, G. I., Swales, J. D., & Thurston, H. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb03393.x · Cited by 51
Klein, I. L., & Ojamaa, K. (2001) · Circulation Research · doi:10.1161/01.res.88.3.260 · Cited by 50
Aggregation of High-Normal Thyroid-Stimulating Hormone in Hypertensive Families
Gumieniak, O., Hurwitz, S., Perlstein, T. S., Ngumezi, U. C., Hopkins, P. N., Jeunemaı̂tre, X., & Williams, G. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0373 · Cited by 19
[Excretion of iodine in the urine. A study from 6 different Norwegian districts in 1985].
Kapelrud, H., Frey, H. M. M., & Theodorsen, L. (1987) · PubMed · Cited by 18
Cited by
Sorted by citations
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Effects of Thyroid Dysfunction on Lipid Profile
Rizos, C. V., Elisaf, M., & Liberopoulos, E. N. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010076 · Cited by 411
Thyroid-Disrupting Chemicals: Interpreting Upstream Biomarkers of Adverse Outcomes
Miller, M. D., Crofton, K. M., Rice, D. C., & Zoeller, R. T. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800247 · Cited by 289
Metadata
- Authors
- Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., & Vatten, L. J.
- Affiliations
- Department of Public Health (B.O. Å., T.I.L.N., L.J.V.), Faculty of Medicine, Norwegian University of Science and Technology, N-7489 Trondheim, Norway
- Oslo University Hospital (NO)
- Norwegian University of Science and Technology (NO)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-03-01
- Volume
- 92
- Issue
- 3
- Pages
- 841-845
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2079601862
- Cited by
- 215
- References
- 29
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 13 · 2021: 9 · 2020: 15 · 2019: 15 · 2018: 17 · 2017: 8 · 2016: 13 · 2015: 12 · 2014: 15 · 2013: 11 · 2012: 18
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Norwegian Institute of Public Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- thyroid-stimulating hormone, blood pressure, hypertension, thyroid function, reference values, systolic blood pressure, diastolic blood pressure, pulse pressure, cardiovascular health
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Pressure, Cross-Sectional Studies, Female, Health Surveys, Humans, Hypertension, Male, Middle Aged, Norway, Reference Values, Thyrotropin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review